Nisen Perry 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Nisen Perry
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2022-06-14−14,479→ 0 total→ Ordinary Shares (14,479 underlying) - Exercise/Conversion
Ordinary Shares
2022-06-14+14,479→ 58,765 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on June 14, 2021 and vested on June 14, 2022.